SCHEMBL5747442

SCHEMBL5747442

COc1ccc(C#Cc2cc(OC)c(OC(C)C)cc2C=O)cc1[O]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
TSHR P16473 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
ERN1 O75460 5/20 0.37
PRKDC P78527 2/20 0.36
ACACB O00763 2/20 0.33
FGFR4 P22455 2/20 0.33
MAPT P10636 2/20 0.33
PDE4B Q07343 2/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TLR2 O60603 1/20 0.32
TLR1 Q15399 1/20 0.32
TLR6 Q9Y2C9 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3941671 0.91 ALDH1A1 (0.41) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL3946740 0.91 ALDH1A1 (0.41) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL5746990 0.88 ALDH1A1 (0.37) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL5746992 0.82 PDE4B (0.37) ALDH1A1ACACBMAPTPDE4BALOX15
SCHEMBL5225656 0.81 ALDH1A1 (0.50) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL6205811 0.81 ACACB (0.36) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL5746874 0.76 ALDH1A1 (0.47) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL15895661 0.74 ALDH1A1 (0.49) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL17765451 0.72 ALDH1A1 (0.46) ALDH1A1TSHRKDM4ETDP1ERN1
SCHEMBL29752019 0.72 ALDH1A1 (0.68) ALDH1A1TSHRKDM4ETDP1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613635-A2 SOLID PHASE SYNTHESIS OF ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2006-01-11 EP disclosed
WO-2004073598-A2 SOLID PHASE SYNTHESIS OF ANTITUMORAL COMPOUNDS PHARMA MAR, S.A.U. (ES) 2004-09-02 WO disclosed